| Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience M Bassetti, N Castaldo, A Cattelan, C Mussini, E Righi, C Tascini, ... International journal of antimicrobial agents 53 (4), 408-415, 2019 | 140 | 2019 |
| Clinical experience with ceftazidime-avibactam for the treatment of infections due to multidrug-resistant Gram-negative bacteria other than carbapenem-resistant Enterobacterales A Vena, DR Giacobbe, N Castaldo, A Cattelan, C Mussini, R Luzzati, ... Antibiotics 9 (2), 71, 2020 | 77 | 2020 |
| Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) M Bassetti, A Vena, DR Giacobbe, M Falcone, G Tiseo, M Giannella, ... Open Forum Infectious Diseases 7 (5), ofaa139, 2020 | 54 | 2020 |
| Clinical efficacy of ceftolozane-tazobactam versus other active agents for the treatment of bacteremia and nosocomial pneumonia due to drug-resistant Pseudomonas aeruginosa A Vena, DR Giacobbe, C Mussini, A Cattelan, M Bassetti Clinical Infectious Diseases 71 (7), 1799-1801, 2020 | 28 | 2020 |
| Early use of canakinumab to prevent mechanical ventilation in select COVID-19 patients: A retrospective, observational analysis A Mastroianni, S Greco, L Chidichimo, F Urso, F Greco, MV Mauro, ... International Journal of Immunopathology and Pharmacology 35, 20587384211059675, 2021 | 13 | 2021 |
| The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection S Marcotullio, M Andreoni, A Antinori, A d'Arminio Monforte, G Di Perri, ... New microbiologica 35 (3), 259-277, 2012 | 12 | 2012 |
| Does tigecycline have a place in therapy for rickettsial infection of the central nervous system? A Mastroianni, S Greco, F Urso, MV Mauro, V Vangeli Infection & Chemotherapy 54 (1), 165, 2022 | 6 | 2022 |
| Oseltamivir and acute hepatitis, reality association or coincidence? A Mastroianni, V Vangeli, S Greco, F Urso, F Greco, L Chidichimo, ... Antiviral Therapy 26 (3-5), 87-92, 2021 | 2 | 2021 |
| Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis A Mastroianni, V Vangeli, L Chidichimo, F Urso, G De Marco, A Zanolini, ... International Journal of Immunopathology and Pharmacology 37, 03946320231189993, 2023 | 1 | 2023 |
| Challenges associated with convalescent plasma infusion therapy during pregnancy, a case report A Mastroianni, S Greco, L Chidichimo, M Vittoria Mauro, F Greco, F Urso, ... Women’s Health Bulletin 9 (2), 118-121, 2022 | 1 | 2022 |
| Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART … A Mastroianni, V Vangeli, S Greco, L Chidichimo, F Urso, MV Mauro, ... Journal of Preventive Medicine and Hygiene 63 (3), E420, 2022 | 1 | 2022 |
| NP-006 DruGhost, the first database of unavailable drugs in Europe–an Italian model: data 1 year after the start of the platform M La Franca, S Oliverio, S Pireddu, C Orsucci, A Garna, R Petti, ... European Journal of Hospital Pharmacy 31 (Suppl 1), A3-A3, 2024 | | 2024 |
| Focus on: lenacapavir A Carissimi, L Del Bono, L Gambitta, G Handschin, R Marra, C Parati, ... Bollettino SIFO 70 (1), 55-59, 2024 | | 2024 |
| Focus on: dalbavancina A Carissimi, L Del Bono, L Gambitta, R Marra, C Parati, V Picerno, F Urso, ... Bollettino SIFO 69 (6), 404-410, 2023 | | 2023 |
| Focus on: maribavir A Carissimi, L Del Bono, L Gambitta, R Marra, C Parati, V Picerno, F Urso, ... Bollettino SIFO 69 (5), 349-353, 2023 | | 2023 |
| Focus on cefiderocol A Carissimi, L Gambitta, R Marra, C Parati, V Picerno, F Urso, F Vivaldi Bollettino SIFO 69 (4), 270-275, 2023 | | 2023 |
| Intrathecal tigecycline is a safe and effective treatment for central nervous system infections A Mastroianni, V Vangeli, MV Mauro, F Urso, R Manfredi, S Greco encephalitis 3 (3), 87, 2023 | | 2023 |
| Candida guilliermondii Peritonitis During Peritoneal Dialysis. Case Report and Literature Review A Mastroianni, V Vangeli, MV Mauro, F Greco, F Urso, R Manfredi, ... Clinical Management Issues 17 (1), 2023 | | 2023 |
| Focus on PrEP (Profilassi pre-esposizione HIV): via libera di AIFA alla rimborsabilità A Carissimi, L Gambitta, R Marra, C Parati, V Picerno, F Urso, F Vivaldi Bollettino SIFO 69 (3), 193-195, 2023 | | 2023 |
| Focus on: bulevirtide A Carissimi, L Gambitta, R Marra, C Parati, V Picerno, F Urso, F Vivaldi Bollettino SIFO 69 (2), 89-92, 2023 | | 2023 |
